Nov 21, 2019
In today’s episode of the ATP Project we Interview Carl Gibson, Chief Executive officer of Complementary Medicines Australia. The team breakdown what the TGA reform means, where ATP supports the movement for safety regulation in Australia from the TGA, but also why the consultation time requires an extension for the business and economic effects it will have on Australian businesses and the consumer choice restrictions that will ensue from the changes.
As always, this is for information purposes only and is not intended to diagnose, treat, prevent or cure any condition. Please consult with your health care professional before making any changes to your current lifestyle.